Skip to main content

Table 3 Patient demographics and comorbidities

From: Outpatient physical therapy bundled payment models are feasible for total hip arthroplasty patients: an evaluation of utilization, cost and outcomes

Demographics and comorbidities

Less than or 16 Sessions (n = 378)

16 + Sessions

(n = 123)

P-value

Age

65.07 ± 10.02

66.31 ± 10.15

0.239

Sex

  

0.038

 Female

191 (50.5)

76 (61.8)

 

 Male

187 (49.5)

47 (38.2)

 

White race

309 (81.7)

90 (73.2)

0.055

BMI

29.18 ± 5.31

29.66 ± 5.62

0.410

ASA 3 + 

126 (33.3)

41 (33.3)

1

OA

366 (96.8)

116 (94.3)

0.274

Fracture

5 (1.3)

5 (4.1)

0.071*

AVN

7 (1.9)

2 (1.6)

1*

Obesity

153 (40.5)

57 (46.3)

0.298

Diabetes

 Type 1 diabetes

1 (0.3)

0 (0)

1*

 Type 2 diabetes

46 (12.2)

15 (12.2)

1

 Type 1 or 2 diabetes

47 (12.4)

15 (12.2)

1

Sleep apnea

47 (12.4)

25 (20.3)

0.043

COPD

14 (3.7)

6 (4.9)

0.597

Liver disease

7 (1.9)

3 (2.4)

0.713*

Asthma

33 (8.7)

13 (10.6)

0.665

AFIB

23 (6.1)

7 (5.7)

1

CHF

2 (0.6)

1 (0.8)

0.571*

CAD

38 (10.1)

10 (8.1)

0.651

ESRD CKD

23 (6.1)

6 (4.9)

0.783

GERD

109 (28.8)

35 (28.5)

1

Anxiety/depression

78 (20.6)

28 (22.8)

0.708

HTN

192 (50.8)

68 (55.3)

0.446

PVD

0 (0)

0 (0)

1

Neoplasm

7 (1.9)

4 (3.3)

0.476*

Anemia

8 (2.1)

4 (3.3)

0.500*

HCC score

0.49 ± 0.29

0.48 ± 0.21

1

  1. P-values < 0.05 are in bold; * Denotes Fisher’s Exact Test; Data are expressed as mean ± SD or n (%); BMI Body mass index, ASA American Society of Anesthesiologists, AVN Avascular necrosis, OA Osteoarthritis, COPD Chronic obstructive pulmonary disease, AFIB Atrial fibrillation, CHF Congestive heart failure, CAD Coronary artery disease, ESRD CKD End-stage renal disease/chronic kidney disease, GERD Gastroesophageal reflux disease, HTN Hypertension, PVD Peripheral vascular disease, HCC Hierarchical condition category